Functional polymorphisms of the FAS/FASLG genes are associated with risk of alopecia areata in a Chinese population: A case-control analysis

British Journal of Dermatology

Volumn 163, Issue 2, 2010, Pages 340-344

  Fan, X ^a   Shangguan, L ^b   Li, M ^b   Li, C Y ^b   Liu, B ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

alopecia areata; Fas; Fas L; polymorphism

Indexed keywords

FAS ANTIGEN; FAS LIGAND;

ADULT; ALOPECIA AREATA; ARTICLE; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGE FACTORS; ALOPECIA AREATA; ANTIGENS, CD95; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FAS LIGAND PROTEIN; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; RISK; SEX DISTRIBUTION; YOUNG ADULT;

EID: 77954874501     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09808.x     Document Type: Article

References (18)

1. Kos L, Conlon J. An update on alopecia areata. Curr Opin Pediatr 2009 21 : 475 480.
2. Sharma K, Wang RX, Zhang LY et al. Death the Fas way: regulation and pathophysiology of CD95 and its ligand. Pharmacol Ther 2000 88 : 333 347.
3. Kavurma MM, Khachigian LM. Signaling and transcriptional control of Fas ligand gene expression. Cell Death Differ 2003 10 : 36 44.
4. Guzman E, Langowski JL, Owen-Schaub L. Mad dogs, Englishmen and apoptosis: the role of cell death in UV-induced skin cancer. Apoptosis 2003 8 : 315 325.
5. Sibley K, Rollinson S, Allan JM et al. Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia. Cancer Res 2003 63 : 4327 4330.
6. Wu J, Metz C, Xu X et al. A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients. J Immunol 2003 170 : 132 138.
7. Li M, Sun D, Li C et al. Functional polymorphisms of the FAS gene associated with risk of vitiligo in Chinese populations: a case-control analysis. J Invest Dermatol 2008 128 : 2820 2824.
8. Agarwal K, Czaja AJ, Donaldson PT. A functional Fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosis. Tissue Antigens 2007 69 : 227 235.
9. Nolsøe RL, Kelly JA, Pociot F et al. Functional promoter haplotypes of the human FAS gene are associated with the phenotype of SLE characterized by thrombocytopenia. Genes Immun 2005 6 : 699 706.
10. Wang W, Lu N, Xia Y et al. FAS and FASLG polymorphisms and susceptibility to idiopathic azoospermia or severe oligozoospermia. Reprod Biomed Online 2009 18 : 141 147.
11. Kemp EH, McDonagh AJ, Wengraf DA et al. The non-synonymous C1858T substitution in the PTPN22 gene is associated with susceptibility to the severe forms of alopecia areata. Hum Immunol 2006 67 : 535 539.
12. Bodemer C, Peuchmaur M, Fraitaig S et al. Role of cytotoxic T cells in chronic alopecia areata. J Invest Dermatol 2000 114 : 112 116.
13. Freyschmidt-Paul P, McElwee KJ, Botchkarev V et al. Fas-deficient C3.MRL-Tnfrsf6(lpr) mice and Fas ligand-deficient C3H/HeJ-Tnfsf6(gld) mice are relatively resistant to the induction of alopecia areata by grafting of alopecia areata-affected skin from C3H/HeJ mice. J Investig Dermatol Symp Proc 2003 8 : 104 108.
14. Kuwahara H, Tani Y, Ogawa Y et al. Therapeutic effect of novel anti-human Fas antibody HFE7a on graft-versus-host disease model. Clin Immunol 2001 99 : 340 346.
15. Alfadhli S, Kharrat NJ, Al-Tememy B et al. Susceptible and protective endothelial nitric oxide synthase gene polymorphism in alopecia areata in Kuwaiti population. Autoimmunity 2008 41 : 522 525.
16. Betz RC, König K, Flaquer A et al. The R620W polymorphism in PTPN22 confers general susceptibility for the development of alopecia areata. Br J Dermatol 2008 158 : 389 391.
17. Geleijns K, Laman JD, van Rijs W et al. Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain-Barré syndrome. J Neuroimmunol 2004 161 : 183 189.
18. Mullighan CG, Heatley S, Lester S et al. Fas gene promoter polymorphisms in primary Sjögren's syndrome. Ann Rheum Dis 2004 63 : 98 101.